Pathophysiology of DUB
Pathophysiology of DUB
Pathophysiology of DUB
1. Anovulatory
Metropathia Haemorrhagica.
Threshold Bleeding.
2.Ovulatory --Idiopathic ovulatory Menorrhagia.
Luteal Phase Defect.
Anovulatory DUB
In some adolescent girls and perimenopausal women,
Ovarian follicles develop(FSH Stimulation) and produce
estrogen in variable amount leading to proliferation of
endometrium
Dominant follicle may not develop due to insufficient LH
surge no ovulationno development of corpus Luteum
--- no progesterone --- no secretory changes in
endometrium ; estrogen still secreted by follicles
(granulosa cells)
Anovulatory DUB
Unopposed estrogenic stimulation and some time
hyper ( super threshold ) level of estrogen results in
over growth of endometrium(hyperplasia)
----resulting in prolonged cycle and increased blood
loss during period.
Anovulatory DUB
When endometrium over grows its blood supply, lack of
progesterone causes decrease PGE2 vasodilators initially
and avascular necrosis of functional endometrium occur ,
endometrium is shade off Lack of vasoconstrictors--PGf2a and thromboxane results in excessive blood loss
which is pain less and prolonged for 20-30days (As
irregular shading of endometrium continues for such a
long time ).
Persistent Follicles undergo the formation of follicular
cysts.
Metropathia Haemorrhagica
Complex Hyperplasia
Threshold Bleeding
This is often seen in perimenopausal women . There is
insufficient development of ovarian follicles resulting in
low estrogen level not able to sustain endometrium or
trigger LH surge ( no ovulation ).
Such women can have prolonged and excessive bleeding
due to absence of progesterone and lack of PGF2a and
thomboxane.
Bleeding PV in these women can be controlled with cyclic
E2 + P Combination Therapy as both are at low level .
Ovulatory DUB
More common in women of reproductive age group (2140 years ) .
Accounts for 20% cases of DUB.
Patient usually present Cyclic excessive bleeding /
premenstrual spotting.
Periods are associated with Pain .
Idiopathic
Ovulatory
Menorrhagia
Normal
Progesterone
ANOVULATORY
Metropathia
Haemorrhagica
Prolonged Oestrogen
No Progesterone
Reduced PG F2
Reduced PG F2
Premenstrual
Spotting
(Polymenorrhoea)
Secretory
Endometrium
Irregular ripening
Amenorrhoea followed
by bleeding
Hyperplastic
Endometrium
Threshold Bleeding
Low Oestrogen
No Progesterone
Reduced PG F2
Polymenorrhoea/
Polymenorrhagia
Proliferative
Endometrium